Amgen (AMGN) shares outstanding

Shares outstanding · fiscal 2025
542.00M

Amgen (AMGN) had 542.00M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.2% higher than the 541.00M of fiscal 2024. Figures as of 18 Nov 2026, 12:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
542.00M
Change on fiscal 2024
+0.2%
Growth, 5 years
−1.7% a year
Growth, 10 years
−3.4% a year
Highest on record
1.12Bfiscal 2007
Lowest on record
538.00Mfiscal 2023
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Amgen shares outstanding, in more detail

The market data feed counts 540.91M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count shrank at a compound 1.7% a year; over ten years the rate was −3.4% a year. Across the 19 fiscal years on record (2007–2025), the highest was 1.12B in fiscal 2007 and the lowest 538.00M in fiscal 2023.

History · 19 fiscal years

Shares outstanding by fiscal year

Amgen shares outstanding, year by year

Amgen (AMGN) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025542.00M 0.2% up
2024541.00M 0.6% up
2023538.00M 0.6% down
2022541.00M 5.6% down
2021573.00M 2.9% down
2020590.00M 3.1% down
2019609.00M 8.4% down
2018665.00M 9.5% down
2017735.00M 2.5% down
2016754.00M 1.6% down
2015766.00M 0.5% down
2014770.00M 0.7% up
2013765.00M 2.8% down
2012787.00M 13.7% down
2011912.00M 5.5% down
2010965.00M 5.5% down
20091.02B 5.0% down
20081.08B 4.3% down
20071.12B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Amgen and comparable companies
CompanyShares outstandingFiscal year
Novartis NVS1.96B2025
AstraZeneca AZN1.56B2025
Thermo Fisher Scientific TMO378.00M2025
Amgen AMGN542.00M2025
Gilead Sciences GILD1.26B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AMGN

Amgen, figure by figure

Amgen (AMGN) overview: price, valuation and scorecardAll health care companies by market value

Amgen shares outstanding: questions and answers

How many shares does Amgen have?

Amgen (AMGN) had 542.00M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.2% higher than the 541.00M of fiscal 2024. The market data feed counts 540.91M shares outstanding today.

What is the growth rate of Amgen's diluted share count?

Over the five fiscal years to 2025 the diluted share count shrank at a compound 1.7% a year; over ten years the rate was −3.4% a year.

What are the highest and lowest diluted share count figures on record for Amgen?

Across the 19 fiscal years on record (2007–2025), the highest was 1.12B in fiscal 2007 and the lowest 538.00M in fiscal 2023.

How is Amgen's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Amgen it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amgen (AMGN) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/AMGN/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.